| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.31 | 9e-06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.009 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-10 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-09 |